In vivo cell-mediated immunity in subjects with undetectable viral load on protease inhibitor-based versus non-protease inhibitor-based highly active antiretroviral therapy

被引：3
|
作者：
Ananworanich, J [1 ]
Nuesch, R
Teeratakulpisam, S
Srasuebkul, P
Chuenyam, T
Siangphoe, U
Ungsedhaphand, C
Phanuphak, P
Ruxrungtham, K
机构：
[1] HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand
[2] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2003年 / 32卷 / 05期
关键词：
D O I：
10.1097/00126334-200304150-00016
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：570 / 572
页数：3
相关论文
共 50 条
  • [1] The role of pharmacological enhancement in protease inhibitor-based highly active antiretroviral therapy
    Becker, SL
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (03) : 401 - 412
  • [2] Immunologic response to protease inhibitor-based highly active Antiretroviral therapy: A review
    Wainberg, Mark A.
    Clotet, Bonaventura
    AIDS PATIENT CARE AND STDS, 2007, 21 (09) : 609 - 620
  • [3] Protease inhibitor-based dual antiretroviral therapy (PIDAT) in clinical practice
    Marshall, N.
    Smith, C.
    Swaden, L.
    Tyrer, M.
    Johnson, M.
    HIV MEDICINE, 2012, 13 : 71 - 72
  • [4] Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy
    Chaparro, J
    Reeds, DN
    Wen, WD
    Xueping, E
    Klein, S
    Semenkovich, CF
    Bae, KT
    Quirk, EK
    Powderly, WG
    Yarasheski, KE
    Li, E
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (05): : 561 - 567
  • [5] Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme
    Wood, E.
    Hogg, R. S.
    Yip, B.
    Moore, D.
    Harrigan, P. R.
    Montaner, J. S. G.
    HIV MEDICINE, 2007, 8 (02) : 80 - 85
  • [6] Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy
    Lima, Viviane D.
    Gill, Vikram S.
    Yip, Benita
    Hogg, Robert S.
    Montaner, Julio S. G.
    Harrigan, P. Richard
    JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (01): : 51 - 58
  • [7] Protease Genotypes in Patients Failing Protease Inhibitor-based Antiretroviral Therapy at a Pediatric Center in Botswana
    Gomila, Andres
    Kirk, Brianna
    Marape, Marape
    Anabwani, Gabriel
    Tolle, Michael
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (10) : 1086 - 1088
  • [8] Factors that predict incomplete virological response to protease inhibitor-based antiretroviral therapy
    Clough, LA
    D'Agata, E
    Raffanti, S
    Haas, DW
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) : 75 - 81
  • [9] Protease inhibitor-based antiretroviral therapy in pregnancy: effects on hormones, placenta, and decidua
    Dunk, Caroline E.
    Serghides, Lena
    LANCET HIV, 2022, 9 (02): : E120 - E129
  • [10] Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy:: Immune response and viral control
    Sufka, SA
    Ferrari, G
    Gryszowka, VE
    Wrin, T
    Fiscus, SA
    Tomaras, GD
    Staats, HF
    Patel, DD
    Sempowski, GD
    Hellmann, NS
    Weinhold, KJ
    Hicks, CB
    JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (07): : 1027 - 1037
12345